Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2006, p. 3926-3928, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00538-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility
Jason Cota,1,2
Michael Carden,2
John R. Graybill,2
Laura K. Najvar,2
David S. Burgess,1,2 and
Nathan P. Wiederhold1,2*
The University of Texas at Austin College of Pharmacy, Austin, Texas,1
The University of Texas Health Science Center at San Antonio, San Antonio, Texas2
Received 1 May 2006/
Returned for modification 19 June 2006/
Accepted 14 August 2006
The activities of anidulafungin and caspofungin against Candida glabrata were evaluated. MICs, 50% inhibitory concentrations (IC50 values), and IC90 values for anidulafungin were lower than those for caspofungin for 16 of 18 strains tested. Anidulafungin has potent in vitro activity against C. glabrata that is maintained against isolates with elevated caspofungin MICs.
* Corresponding author. Mailing address: University of Texas at Austin College of Pharmacy, UTHSCSA, Clinical Pharmacy, MSC 6220, 7703 Floyd Curl Drive, San Antonio, TX 78229. Phone: (210) 567-8340. Fax: (210) 567-8328. E-mail:
wiederholdn{at}uthscsa.edu.
Published ahead of print on 28 August 2006.
Antimicrobial Agents and Chemotherapy, November 2006, p. 3926-3928, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00538-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Andes, D. R., Diekema, D. J., Pfaller, M. A., Marchillo, K., Bohrmueller, J.
(2008). In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model. Antimicrob. Agents Chemother.
52: 3497-3503
[Abstract]
[Full Text]
-
Thompson, G. R. III, Wiederhold, N. P., Vallor, A. C., Villareal, N. C., Lewis, J. S. II, Patterson, T. F.
(2008). Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection. Antimicrob. Agents Chemother.
52: 3783-3785
[Abstract]
[Full Text]
-
Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., Wiederhold, N. P.
(2008). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrob. Agents Chemother.
52: 1144-1146
[Abstract]
[Full Text]
-
Andes, D., Diekema, D. J., Pfaller, M. A., Prince, R. A., Marchillo, K., Ashbeck, J., Hou, J.
(2008). In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model. Antimicrob. Agents Chemother.
52: 539-550
[Abstract]
[Full Text]
-
Wiederhold, N. P., Najvar, L. K., Bocanegra, R., Molina, D., Olivo, M., Graybill, J. R.
(2007). In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera. Antimicrob. Agents Chemother.
51: 1616-1620
[Abstract]
[Full Text]